featured
Oxaliplatin and 5-FU/Folinic Acid With or Without Aflibercept in First-Line Treatment of Metastatic Colorectal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Oxaliplatin and 5-FU/Folinic Acid (Modified FOLFOX6) With or Without Aflibercept in First Line Treatment of Patients With Metastatic Colorectal Cancer—The AFFIRM Study
Ann. Oncol 2016 Apr 18;[EPub Ahead of Print], G Folprecht, C Pericay, MP Saunders, A Thomas, RL Lopez, JK Roh, V Chistyakov, T Höhler, JS Kim, RD Hofheinz, SP Ackland, D Swinson, M Kopp, D Udovitsa, M Hall, T Iveson, A Vogel, JR ZalcbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.